James Dorian Otvos
James Dorian Otvos publishes mostly in Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Diabetes, Cardiovascular Risks, and Lipoproteins, Lipoproteins and Cardiovascular Health and Cardiovascular Health and Disease Prevention.
- World rank
- #108,266 of 7,710,434 ranked researchers
- Rank in United States
- #41,351 of 1,627,098
- Works
- 380
- Citations
- 23k
- Citations per work
- 60.2
What does James Dorian Otvos research?
James Dorian Otvos's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences19451.1%
- Medicine19451.1%
- Everything else15941.9%
- Life Sciences277.0%
- 1Endocrinology, Diabetes and Metabolism18% of their works
- 2Cardiology and Cardiovascular Medicine12% of their works
- 3Surgery11% of their works
- 4Molecular Biology7% of their works
- 5Epidemiology6% of their works
- 6Physiology4% of their works
Research topics
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Lipoproteins and Cardiovascular Health
- Cardiovascular Health and Disease Prevention
- Metabolomics and Mass Spectrometry Studies
- Adipokines, Inflammation, and Metabolic Diseases
- Liver Disease Diagnosis and Treatment
- Cancer, Lipids, and Metabolism
- Lipid metabolism and disorders
Which keywords describe James Dorian Otvos's research?
The keywords of their largest research topics: Metabolic Syndrome, Insulin Resistance, Cardiovascular Disease, Obesity, Atherosclerosis, Cholesterol, Diabetes and Glucose Metabolism.
- Lipid Metabolism
- ANGPTL3
- NAFLD
- Adipokines
- Mass Spectrometry
- Arterial Stiffness
- Cholesterol-lowering
- Statins
- Glucose Metabolism
- Cholesterol
- Obesity
- Insulin Resistance
- Metabolic Syndrome
- Cardiovascular Disease
- Atherosclerosis
- Diabetes
- C-Reactive Protein
- Cardiovascular Disease Prevention
- Adipose Tissue
- Endothelial Dysfunction
- Metabolomics
- Inflammation
- NASH
- Fatty Acid Synthase
- Lipoprotein Lipase
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Metabolic Syndrome2404 topics
- Insulin Resistance2163 topics
- Cardiovascular Disease1872 topics
- Obesity1872 topics
- Atherosclerosis1792 topics
- Cholesterol1792 topics
- Diabetes1551 topic
- Glucose Metabolism1551 topic
- C-Reactive Protein1222 topics
- Statins1142 topics
- Cardiovascular Disease Prevention901 topic
- Cholesterol-lowering901 topic
- Adipose Tissue562 topics
- Arterial Stiffness351 topic
- Endothelial Dysfunction351 topic
- Mass Spectrometry341 topic
- Metabolomics341 topic
- Adipokines321 topic
- Inflammation321 topic
- NAFLD291 topic
- NASH291 topic
- ANGPTL3241 topic
- Fatty Acid Synthase241 topic
- Lipid Metabolism241 topic
- Lipoprotein Lipase241 topic
Where does James Dorian Otvos work?
James Dorian Otvos's main affiliation in the publication record is LabCorp (United States), United States.
How many publications and citations does James Dorian Otvos have?
OpenAlex counts 380 works and 22,866 citations for James Dorian Otvos, an h-index of 73, ranking #108,266 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about James Dorian Otvos. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.